Skip to main content
Evolving Option For HBV Therapy: Navigating The New Treatment Landscape

Evolving Option For HBV Therapy: Navigating The New Treatment Landscape

Enroll in HCVC0017

Starts

Offered by Mylanhepatocare Mylanhepatocare

Key Fact

  • Price Free
  • Language English

Share your Case Studies

Come join our "Learn as you Teach" initiative to democratise healthcare learning by submitting your unique & interesting Case-Studies which will be reviewed by our global medical fraternity as well as an opportunity to be published in leading research journals.

Meet the Instructor

Course Staff Image #1

Dr. Henry Chan

MD, FRCP, FHKCP, FHKAM, MBCHB.
Professor Henry Lik Yuen Chan, MBChB, MD, FRCP, FHKCP, FHKAM graduated from The Chinese University of Hong Kong (CUHK) and obtained his Doctor of Medicine with commendation in 2001. He is currently Head of Division of Gastroenterology and Hepatology, Director of Institute of Digestive Disease, Director of Center for Liver Health, Director of Office of Global Engagement, and Assistant Dean (External Affairs) of Faculty of Medicine, CUHK. He is the course director of Master of Science in Gastroenterology, CUHK.
Professor Chan is a key investigator in over 25 international trials on antiviral treatment of chronic hepatitis B and C, and is the global lead author in publications on peginterferon, telbivudine and tenofovir alafenamide for the treatment of viral hepatitis B. He has received numerous local, national and international research awards. He has published over 350 papers in peer-reviewed journals.

Enroll